These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 7681078)

  • 1. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
    López D; Rojo S; Calvo V; López de Castro JA
    J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
    Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
    Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.
    López D; García-Hoyo R; López de Castro JA
    J Immunol; 1994 Jun; 152(11):5557-71. PubMed ID: 8189072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
    Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
    J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
    Aparicio P; Jaraquemada D; López de Castro JA
    J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
    Calvo V; Rojo S; López D; Galocha B; López de Castro JA
    J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
    García-Peydró M; Martí M; López de Castro JA
    J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
    Rojo S; López D; Calvo V; López de Castro JA
    J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
    Villadangos JA; Galocha B; López de Castro JA
    J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
    Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
    J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705.
    Villadangos JA; Galocha B; García-Hoyo R; López D; García F; López de Castro JA
    Eur J Immunol; 1994 Oct; 24(10):2548-55. PubMed ID: 7523146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.